Evidence map›Paper›PMID 33192504›Full record

ArticleFrontiers in pharmacology2020

Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of

Decio Armanini, Cristina Fiore, Jens Bielenberg, Chiara Sabbadin, Luciana Bordin

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04487964 (Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04487964 nacompletednot on this map

Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine

TypeinterventionalSponsorEgyptian Biomedical Research NetworkRan2020 to 2021Enrolled50ConditionsCOVID-19ArmsLicorice extract
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Revisiting liquorice (Phytomedicine plus : international journal of phytotherapy and phytopharmacology · 2022
    Review
  5. Article
  6. Article
  7. Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Decio ArmaniniDepartment of Medicine-Endocrinology, University of Padua, Padua, Italy.
Cristina FioreDepartment of Medicine-Endocrinology, University of Padua, Padua, Italy.
Jens BielenbergDepartment of Medicine-Endocrinology, University of Padua, Padua, Italy.
Chiara SabbadinDepartment of Medicine-Endocrinology, University of Padua, Padua, Italy.
Luciana BordinDepartment of Molecular Medicine-Biological Chemistry, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

https://clinicaltrials.gov/ (NCT044241349, NCT043465887, NCT04487964).

Indexed as

androgen receptorinflammationlicoriceplasma membranespironolactone

Identifiers

PMID33192504
PMCPMC7642094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.